CF nasal rinse breakthrough? study tests if less is more

NCT ID NCT06996951

Recruiting now Knowledge-focused Sponsor: Indiana University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether people with cystic fibrosis who are on highly effective modulator therapy can safely stop using nasal saline rinses and steroid sprays. Researchers will monitor sinus health, lung function, and quality of life in 64 adults. The goal is to see if these standard treatments are still needed in the era of new CF medications.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: nasal saline irrigation with or without steroid
What this could lead to: If successful, this could show that some standard nasal treatments are no longer needed for CF patients on highly effective modulator therapy, simplifying daily care.
What could go wrong: This is a small Phase 3 study with only 64 participants. Stopping nasal therapies might worsen sinus symptoms or lead to infections in some patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC RHINOSINUSITIS (CRS) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic rhinosinusitis cystic fibrosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHRONIC RHINOSINUSITIS (CRS) CYSTIC FIBROSIS (CF)

Contacts and locations

Locations

Indiana University Health
RECRUITING

Indianapolis, Indiana, 46202, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.